146 completed, 19 unknown, 10 recruiting, 8 terminated. 65 Phase 3, 48 Phase 2, 40 Phase 4, 14 Not applicable, 12 Phase 1.
Follow Conjunctivitis, Allergic: new trials by email Literature Review of Conjunctivitis, Allergic trials Research Report on Conjunctivitis, Allergic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigating Nasal and Ocular Immune Response to Conjunctival Allergen Exposure Standardized Allergen Extract, Timothy Grass (Phleum pratense) - Allergic Rhinoconjunctivitis | Recruiting | Dr. Anne Ellis | 12 | 2026-09-01 | 2026-10-01 | |
| A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch Allergy Noninterventional - Conjunctivitis Allergic | Not yet recruiting | Regeneron Pharmaceuticals | 1500 | 2026-08-17 | 2026-07-17 | |
| A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy REGN-2Cat, Freneslerbart, Mevonlerbart - Allergic Conjunctivitis | Phase 3 | Recruiting | Regeneron Pharmaceuticals | 570 | 2026-07-31 | 2026-08-12 |
| Daydrop® Triple Action for Allergic Eye Symptoms Eye Drops, Lubricant - Allergic Conjunctivitis of Both Eyes | Not applicable | Recruiting | i+Med S.Coop. | 49 | 2026-06-08 | 2026-09-04 |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED Cenegermin, Vehicle - Persistent Corneal Epithelial Defect | Phase 3 | Recruiting | Dompé Farmaceutici S.p.A | 150 | 2026-06-02 | 2026-10-07 |
| A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis Slit Lamp Examination, Far Best Corrected Visual Acuity (BCVA), T1695 - Moderate to Severe Vernal Keratoconjunctivitis | Phase 2 | Recruiting | Laboratoires Thea | 120 | 2026-03-24 | 2026-04-22 |
| 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis 3% Diquafosol ophthalmic solution and 0.1% Cyclosporin A cationic ophthalmic emulsion, 0.1% Cyclosporin A cationic ophthalmic emulsion - Vernal Keratoconjunctivitis | Phase 3 | Recruiting | The University of Hong Kong | 94 | 2026-02-09 | 2026-04-30 |
| Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy REGN5713, REGN5715, Placebo - Allergic Conjunctivitis | Phase 3 | Terminated | Regeneron Pharmaceuticals | 24 | 2026-01-10 | 2026-09-01 |
| OJO-miR: microRNA Expression in Allergic Conjunctivitis. Conjunctivitis, Allergic | Active not recruiting | Instituto de Oftalmología Fundación Conde de Valenciana | 40 | 2026-01-05 | 2026-02-04 | |
| Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy Conjunctivitis, Allergic | Not yet recruiting | Instituto de Oftalmología Fundación Conde de Valenciana | 60 | 2026-01-01 | 2025-09-17 | |
| Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects Allergic Rhinitis, Allergic Conjunctivitis | Not yet recruiting | Sven Schneider, MD | 152 | 2025-12-01 | 2025-05-07 | |
| Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis TL-925, Placebo - Allergic Conjunctivitis | Phase 2 | Recruiting | Telios Pharma, Inc. | 60 | 2025-10-23 | 2025-11-25 |
| Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctivitis Steroid eye drops, Tacrolimus eye drops - Vernal Keratoconjunctivitis | Not applicable | Not yet recruiting | Sohag University | 90 | 2025-09-01 | 2025-08-24 |
| Treatment of Ocular Surface Inflammations Topical Cyclosporine 1% - Ocular Surface Allergy, Conjunctivitis, Allergic | Recruiting | Semmelweis University | 50 | 2025-06-10 | 2026-08-03 | |
| Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical Steroids Vernal Keratoconjunctivitis | Active not recruiting | Superior University | 34 | 2025-03-20 | 2025-04-06 | |
| Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis Probiotic, Placebo Drug - Probiotic, Ocular Surface Disease | Phase 1 | Not yet recruiting | Mohsen Pourazizi | 32 | 2025-02-01 | 2025-01-27 |
| A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy REGN5713, REGN5715, Placebo - Allergic Conjunctivitis | Phase 3 | Completed | Regeneron Pharmaceuticals | 54 | 2024-11-19 | 2026-04-21 |
| A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy REGN1908, REGN1909, Placebo - Allergic Conjunctivitis | Phase 3 | Completed | Regeneron Pharmaceuticals | 64 | 2024-11-06 | 2026-05-08 |
| Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis TL-925, Placebo - Allergic Conjunctivitis | Phase 2 | Recruiting | Telios Pharma, Inc. | 66 | 2024-10-03 | 2024-11-13 |
| A Study Of TL-925 For The Treatment of AC TL-925, Placebo - Allergic Conjunctivitis | Phase 2 | Completed | Telios Pharma, Inc. | 80 | 2024-04-11 | 2024-07-03 |
Showing 20 of 197. Sign in to see all of them.
Rhinitis, Allergic (24) · Hypersensitivity (16) · Rhinitis, Allergic, Seasonal (14) · Conjunctivitis (13) · Asthma (11) · Dry Eye Syndromes (6) · Dermatitis, Atopic (5) · Lacerations (4) · Food Hypersensitivity (3) · Keratoconjunctivitis (3) · Inflammation (2) · Chronic Urticaria (1) · Dust Mite Allergy (1) · Keratoconjunctivitis, Infectious (1)
Conjunctival Diseases (197) · Eye Diseases (197) · Hypersensitivity, Immediate (197) · Immune System Diseases (197) · Conjunctivitis (184) · Hypersensitivity (181) · Respiratory Hypersensitivity (35) · Respiratory Tract Diseases (35) · Nose Diseases (34) · Otorhinolaryngologic Diseases (34) · Rhinitis (34) · Bronchial Diseases (11) · Lung Diseases (11) · Lung Diseases, Obstructive (11) · Rhinitis, Allergic (10)
Olopatadine Hydrochloride (29) · Ophthalmic Solutions (11) · Ketotifen (9) · bepotastine besilate (8) · alcaftadine (7) · Dexamethasone (6) · Lubricant Eye Drops (6) · Tacrolimus (6) · Loteprednol Etabonate (5) · Cyclosporine (4) · Dextrans (3) · Fluticasone (3) · Methylprednisolone (3) · Naphazoline (3) · prednisolone acetate (3)
Alcon Research (21) · Bausch & Lomb Incorporated (15) · Allergan (9) · Vistakon Pharmaceuticals (9) · ORA, Inc. (8) · Aldeyra Therapeutics, Inc. (7) · Regeneron Pharmaceuticals (6) · Aciex Therapeutics, Inc. (5) · Faes Farma, S.A. (4) · Telios Pharma, Inc. (4) · Hom, Milton M., OD, FAAO (3) · Laboratoires Thea (3) · Laboratorios Leti, S.L. (3) · Allergy Therapeutics (2) · Andover Research Eye Institute (2)
United States (90) · Canada (13) · Italy (11) · Japan (11) · France (9) · Germany (9) · Spain (9) · South Korea (7) · China (5) · India (5) · Austria (4) · Israel (4) · Mexico (4) · Poland (4) · United Kingdom (4)
Brian Pall, OD, MS, FAAO (4) · Abhijit Narvekar, MS, MBBS (3) · Gail L Torkildsen, MD (3) · Tim McNamara, PharmD (3) · Edward Meier, MD (2) · Gail Torkildsen, MD (2) · Henry J. Crampton, MD (2) · Ingerman Avner, MD (2) · Jack V Greiner, OD, DO, PhD (2) · Jon Williams, PhD (2) · Michael Goldstein, MD (2) · Milton M Hom, OD FAAO (2)
PMID 22991696, PMID 25260889, PMID 27466061, PMID 16713521, PMID 16877412, PMID 17021840, PMID 17585003, PMID 18595980, PMID 19127072, PMID 19302250, PMID 19843481, PMID 20488431, PMID 20642205, PMID 20874810, PMID 21250860, PMID 21530362, PMID 21771081, PMID 21771118, PMID 22093109, PMID 23484763, PMID 23498595, PMID 24517417, PMID 25104279, PMID 25163405, PMID 26141262, PMID 26266427, PMID 27050351, PMID 27430124, PMID 28007090, PMID 28803239, PMID 30326954, PMID 30472801, PMID 32407947, PMID 33144336, PMID 33934706, PMID 34857814, PMID 34901095, PMID 35585427, PMID 36811846, PMID 37438187, PMID 37872059, PMID 38105911, PMID 38687061, PMID 39328900, PMID 39386177
2025 (2), 2005 (1), 2016 (1), 2018 (1), 2019 (1), R01EY012526 (1)